Related Experiment Video
Updated: Apr 30, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
65.9K
Minimizing immunosuppression in islet xenotransplantation
Jun-Seop Shin1, Jung-Sik Kim, Jong-Min Kim
1Translational Xenotransplantation Research Center, Seoul National University College of Medicine, 103 Daehak-ro Jongno-gu, Seoul 110-799, Korea.
Immunotherapy
|May 13, 2014
Summary
Xenotransplantation using pig islets offers a potential solution for Type 1 diabetes due to organ shortages. This review examines immune rejection and immunosuppression strategies to advance clinical trials for pig islet transplantation.
Area of Science:
- Immunology
- Transplantation Biology
- Endocrinology
Background:
- Type 1 diabetes presents a significant health challenge, with pancreatic islet transplantation being a viable treatment.
- Shortage of human donor organs limits the widespread application of islet transplantation.
- Xenotransplantation, specifically using porcine (pig) islets, is a promising alternative source.
Purpose of the Study:
- To review immune rejection mechanisms in islet xenotransplantation.
- To evaluate immunosuppression regimens that promote long-term graft survival in preclinical models.
- To propose strategies for minimizing immunosuppression for clinical application in Type 1 diabetes.
Main Methods:
- Comprehensive review of existing literature on islet xenotransplantation.
- Analysis of immune rejection pathways specific to pig-to-human transplantation.
- Examination of current and emerging immunosuppressive drugs and their targets.
- Evaluation of preclinical data from pig-to-nonhuman primate studies.
Main Results:
- Established consensus guidelines for donor selection, islet production, and preclinical data for xenotransplantation.
- Identified key immune barriers to successful xenograft survival.
- Highlighted immunosuppression regimens that have shown efficacy in nonhuman primate models.
- Discussed strategies to reduce the intensity and duration of immunosuppression.
Conclusions:
- Pig islet xenotransplantation holds significant promise for treating Type 1 diabetes.
- Overcoming immune rejection and optimizing immunosuppression are critical for clinical success.
- Further research into minimizing immunosuppression is essential to reduce patient side effects and facilitate clinical trials.
